Moderna Has Begun Trials For Coronavirus Vaccine With The Help Of 30,000 Volunteers

The following article, Moderna Has Begun Trials For Coronavirus Vaccine With The Help Of 30,000 Volunteers, was first published on Flag And Cross.

Moderna, a true giant in the field of biotech, has now launched the world’s largest COVID-19 vaccination trials on Monday with the help of 30,000 volunteers. The project is being tested both for its effectiveness in preventing folks from contracting the illness and how safe the vaccine is for the average person to take.

Whether or not a coronavirus can be helped with a vaccine is still up in the air.

Here’s more from The Washington Examiner:

“We are pleased to have started the Phase 3 COVE study,” said Stephane Bancel, the company’s CEO. “We look forward to this trial demonstrating the potential of our vaccine to prevent COVID-19, so that we can defeat this pandemic.”

Moderna will enroll about 30,000 people across 89 sites to test shots developed in part by the National Institutes of Health. In the Phase 3 study, called the COVE, or Coronavirus Efficacy, half of all participants will receive two shots of the vaccine candidate 28 days apart, and the other half will receive two shots of a placebo. Testing will also aim to determine if the shots of the vaccine can protect from severe infections of COVID-19 and death.

Researchers will monitor volunteers for side effects after the doses are administered, as well as for signs that the vaccine protects them from getting COVID-19. Preliminary testing results from Moderna found that volunteers experienced only minor side effects, such as fatigue and fever. While several vaccine candidates in addition to Moderna’s have been shown to induce immune responses, none have been shown to protect against the coronavirus disease.

While no one should attempt to downplay the coronavirus, it’s also critical to examine all of the scientific data that is being produced and not just the information coming out from one side of the issue.

A lot of the studies being conducted right now contain conflicting information. This makes it difficult to make good choices concerning how to deal with the virus and how best to protect people, particularly those at high risk of contracting it.

Here’s to hoping that if a vaccine is found to be useful in the prevention of coronavirus, that it is thoroughly vetted and is left up to individuals to choose whether or not they want to take it.

Continue reading: Moderna Has Begun Trials For Coronavirus Vaccine With The Help Of 30,000 Volunteers ...